TY - JOUR
T1 - Factors affecting regression of mitral regurgitation following isolated coronary artery bypass surgery
AU - Campwala, Saida Zen
AU - Bansal, Ramesh C.
AU - Wang, Nan
AU - Razzouk, Anees
AU - Pai, Ramdas G.
N1 - CABG = coronary artery bypass graft surgery, CVA = cerebral vascular accident, EKG = Electrocardiogram, IMR = ischemic mitral regurgitation, LA = left atrium, LV = left ventricle, LVd = left ventricle end diastolic dimension, LVEF = left ventricle ejection fraction, LVs = left ventricle end systolic dimension, MR = mitral regurgitation, NSR = normal sinus rythum, NYHA = New York Heart Association Class MR is common and present in 3-7% of patients undergoing CABG [1, 2].
PY - 2005/7
Y1 - 2005/7
N2 - Objective: Fate of MR following CABG is variable. Predictors of MR regression following CABG alone are not known. Methods: From our surgical registry, CABG patients with both pre-operative and post-operative resting echocardiograms at our institution were screened. Of the 523 patients identified, 92 had 3+ (n=65) or 4+ (n=27) MR on the pre-operative echocardiogram on a 0-4 scale, who had isolated CABG. MR regression was correlated with clinical, operative, electrocardiographic and echocardiographic variables. Results: Patient characteristics: age 68±11 years, 62% male, and LVEF 37±15%. MR grade decreased from 3.3±0.5 to 2.3±1.2 post-CABG. Residual 3 or 4+ MR post-CABG was present in 43 (47%) patients. Regression of MR (n=49) was associated with reductions in LV end-diastolic (P=0.006) and end-systolic (P=0.0005) dimensions, improvement in LVEF (P=0.01), longer cross-clamp time (P=0.04), use of beta-blockers (P=0.04) and lower presence of CVA as a possible marker of lower atherosclerotic burden (P=0.03). There was a trend towards increased mortality (P=0.3) with residual 3-4+ MR over a mean follow-up of 3.9 years. Conclusions: In nearly half of patients with 3-4+ MR, MR does not regress with CABG alone. Residual MR may be associated with increased mortality. Regression of MR is related to LV size reduction and improvement in LV function. Presence of myocardial viability, adequate revascularization, lack of excessive atherosclerotic burden and therapy with beta-blockers and ace-inhibitors may be critical for MR regression following CABG alone. © 2005 Elsevier B.V. All rights reserved.
AB - Objective: Fate of MR following CABG is variable. Predictors of MR regression following CABG alone are not known. Methods: From our surgical registry, CABG patients with both pre-operative and post-operative resting echocardiograms at our institution were screened. Of the 523 patients identified, 92 had 3+ (n=65) or 4+ (n=27) MR on the pre-operative echocardiogram on a 0-4 scale, who had isolated CABG. MR regression was correlated with clinical, operative, electrocardiographic and echocardiographic variables. Results: Patient characteristics: age 68±11 years, 62% male, and LVEF 37±15%. MR grade decreased from 3.3±0.5 to 2.3±1.2 post-CABG. Residual 3 or 4+ MR post-CABG was present in 43 (47%) patients. Regression of MR (n=49) was associated with reductions in LV end-diastolic (P=0.006) and end-systolic (P=0.0005) dimensions, improvement in LVEF (P=0.01), longer cross-clamp time (P=0.04), use of beta-blockers (P=0.04) and lower presence of CVA as a possible marker of lower atherosclerotic burden (P=0.03). There was a trend towards increased mortality (P=0.3) with residual 3-4+ MR over a mean follow-up of 3.9 years. Conclusions: In nearly half of patients with 3-4+ MR, MR does not regress with CABG alone. Residual MR may be associated with increased mortality. Regression of MR is related to LV size reduction and improvement in LV function. Presence of myocardial viability, adequate revascularization, lack of excessive atherosclerotic burden and therapy with beta-blockers and ace-inhibitors may be critical for MR regression following CABG alone. © 2005 Elsevier B.V. All rights reserved.
KW - CABG
KW - Mitral regurgitation
KW - Severity of Illness Index
KW - Mitral Valve Insufficiency/diagnostic imaging
KW - Drug Administration Schedule
KW - Ventricular Function, Left
KW - Humans
KW - Middle Aged
KW - Male
KW - Treatment Outcome
KW - Coronary Disease/complications
KW - Ultrasonography
KW - Coronary Artery Bypass
KW - Electrocardiography
KW - Female
KW - Aged
KW - Retrospective Studies
KW - Angiotensin-Converting Enzyme Inhibitors/administration & dosage
KW - Adrenergic beta-Antagonists/administration & dosage
UR - https://www.scopus.com/pages/publications/21244505815
UR - https://www.scopus.com/pages/publications/21244505815#tab=citedBy
UR - https://www.mendeley.com/catalogue/2fd8b4f9-d849-344b-8baf-649a17fa18d1/
U2 - 10.1016/j.ejcts.2005.03.026
DO - 10.1016/j.ejcts.2005.03.026
M3 - Article
C2 - 15939601
SN - 1010-7940
VL - 28
SP - 104
EP - 108
JO - European Journal of Cardio-thoracic Surgery
JF - European Journal of Cardio-thoracic Surgery
IS - 1
ER -